Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2022 PharmSci 360 Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Sharon Amzel-Sasson, Pharm D., MBA
Orasis Pharmaceuticals, Israel
Poster(s):
(T1130-04-23) Development of a Low-Dose Pilocarpine Ophthalmic Formulation that is Stable, Well-Tolerated and Bioavailable at a Near-Neutral pH for the Treatment of Presbyopia
Tuesday, October 18, 2022
11:30 AM – 12:30 PM
ET
